Will rescheduling reroute the future of interstate commerce for cannabis?

Some cannabis executives are hopeful that if the federal government moves marijuana from Schedule 1 to 3 of the Controlled Substances Act, then transporting MJ products across state lines will be allowed.

DEA likely to OK marijuana rescheduling, but election and lawsuits could get in the way

From zealous drug warrior to out-of-touch elder statesman to the regulated marijuana industry’s savior apparent.

President Joe Biden’s long arc in public life might have more twists ahead.

Republican-led federal marijuana legalization effort reappears in Congress

A bipartisan but Republican-led effort to legalize marijuana federally was reintroduced in Congress last week, but chances for passage might be slim in the House under new Speaker Mike Johnson.

Marijuana companies suing US attorney general in federal prohibition challenge

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

New US House Speaker Mike Johnson has opposed marijuana reform

Hard-right conservative Mike Johnson, chosen by House Republicans on Wednesday to be the chamber’s new speaker, has been a staunch opponent of marijuana reform in Congress.

DEA is ‘likely’ to reschedule marijuana, government analysis predicts

The U.S. Drug Enforcement Administration will “likely” reschedule marijuana, following federal health regulators’ Aug. 29 recommendation, according to a government analysis.

Opinion: Marijuana rescheduling is positive, but we must go further and faster

Rescheduling marijuana is positive news in an industry desperate for good news. But make no mistake, it is not enough.

14 congressional Republicans oppose proposed marijuana rescheduling

Fourteen Republican federal lawmakers are voicing their opposition to a key federal agency’s recent recommendation that marijuana be rescheduled.

Once a marijuana enemy, DEA now key to rescheduling

The most significant shift in U.S. marijuana policy is drawing closer, but one major obstacle remains in reform’s way: the Drug Enforcement Administration.

2nd-quarter cannabis MSO earnings ‘not terrible,’ analyst says

The nation’s largest cannabis multistate operators reported a slowdown in revenue growth in the second quarter, which ended June 30, with efforts to cut costs offset by oversupplied state markets.

‘Biggest thing, ever’: Marijuana rescheduling recommendation hailed

The disclosure Wednesday that top Biden administration health officials this week officially recommended marijuana be reclassified from a Schedule 1 substance to Schedule 3 – the same category as Tylenol with codeine – was hailed as the biggest development in MJ policy reform in more than 50 years. 

Opinion: Don’t count on federal courts to rule on cannabis lawsuits

Parties to a cannabis dispute should not rush back into federal court, which has made clear that marijuana cases are not welcome.